Synthesis, characterization, and antimicrobial activity of 3′-(4-(2-substituted thiazol-4-yl)phenyl)spiro[indoline-3,2′- thiazolidine]-2,4′-dions

Journal of Heterocyclic Chemistry

Volumn 47, Issue 6, 2010, Pages 1415-1420

  Mhaske, Pravin C ^a   Shelke, Shivaji H ^b   Jadhav, Rahul P ^b   Raundal, Hemant N ^b   Patil, Sachin V ^b   Patil, Amar A ^b   Bobade, Vivek D ^b  

^a SP College   (India)

^b H P T Arts and R Y K Science College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3' [4 (2 BENZYLTHIAZOL 4 YL)PHENYL]SPIRO[INDOLINE 3,2' THIAZOLIDINE] 2,4' DIONE; 3' [4 [2 (4 METHOXYBENZYL)THIAZOL 4 YL]PHENYL]SPIRO[INDOLINE 3,2' THIAZOLIDINE] 2,4 DIONE; 5 CHLORO 3' [4 [2 (4 METHOXYBENZYL)THIAZOL 4 YL]PHENYL]SPIRO[INDOLINE 3,2' THIAZOLIDINE] 2,4' DIONE; ANTIINFECTIVE AGENT; CIPROFLOXACIN; INDOLIZIDINE DERIVATIVE; NYSTATIN; SPIRO COMPOUND; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 78649666112     PISSN: 0022152X     EISSN: 19435193     Source Type: Journal    
DOI: 10.1002/jhet.503     Document Type: Article

References (17)

1. Wolf, M.; Masciffi, A. A., US Pat. 3,395,156, 1968; Chem Abstr 1988, 69, 96504r.
2. Rohm, Hoss Co. Brit. Pat. 913,937, 1962; Chem Abstr 1963, 59, 577f.
3. Winters, G.; Mola, N. D., Ger. Pat. 2,442,667, 1975; Chem Abstr 1975, 83, 28096.
4. Kornet, N. J.; Thio, A. P., J Med Chem 1976, 19, 892.
5. Joshi, K. C.; Dandia, A.; Bhajat, S. J., Fluor Chem 1990, 48, 169.
6. Popp, F. D.; Rajopadhye, M., J Heterocycl Chem 1985, 22, 93.
7. Rindhe, S. S.; Mane, R. A.; Ingle, D. B., J Ind Chem Soc 1985, 62, 334.
8. Mashelkar, U. C.; Rane, D. M., Ind J Chem 2005, 44B, 1937.
9. Joshi, K. C.; Dandia, A.; Bhajat, S., Ind J Chem 1990, 29B, 766.
10. Bhambi, D.; Sharma, C.; Sharma, S.; Salvi, V. K.; Talesara, G. L., Ind J Chem 2009, 48B, 1006.
11. Rajopadhye, M.; Popp, F. D., J Heterocycl Chem 1984, 21, 289.
12. Mogilaiah, K.; Rao, R. B., Ind J Chem 1998, 37B, 894.
13. Jain, S. C.; Sinha, J.; Bhagat, S.; Errington, W.; Olsen, C. E., Syn Commun 2003, 33, 563.
14. Cruickshank, R.; Duguid, J. P.; Marion, B. P.; Swain, R. H. A., Medicinal Microbiology, 12th ed.; Vol. 2, Churchil Livingstone: London, 1975, p 196.
15. Collins, H. A., Microbiological Methods, 2nd ed.; Butterworth: London, 1976.
16. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. NCCLS Approval Standard Document M7-A6. National Committee for Clinical Laboratory Standards: Wayne, PA, 2003.
17. NCCLS Approval Standard Document M2-A7. National Committee for Clinical Laboratory Standards: Vilanova, PA, 2000.